Category Archives: Mammary Cell

Mammary Cell News is an online publication and email newsletter covering the latest research into breast cancer and mammary cells.
Subscribe
For over a decade, Mammary Cell News has been keeping the global scientific and medical communities informed about the latest research, reviews, and news in the field of mammary tissues. Our editors gather publications on the topic of mammary cell differentiation and characterization, as well as the progression and treatment of breast cancer. We also keep scientists up-to-date on the latest policy changes, job postings, and events.

Combination of 131I-Trastuzumab and Lanatoside C Enhanced Therapeutic Efficacy in HER2 Positive Tumor Model

Scientists investigated the therapeutic efficacy of the combination of 131I-trastuzumab and lanatoside C for inhibition of human epidermal growth factor receptor 2 (HER2) positive tumor progression in NCI-N87 xenograft model.
[Scientific Reports]
Full Article
Bookmark

No account yet? Register

0
Share

Long Noncoding RNA AFAP1-AS1 Promotes Tumor Progression and Invasion by Regulating the miR-2110/Sp1 Axis in Triple-Negative Breast Cancer

Researchers used Cell Counting Kit-8, colony formation, wound healing migration, Transwell invasion, and nude mouse xenograft assays to confirm the role of the lncRNA actin filament-associated protein 1 antisense RNA1 (AFAP1-AS1) in the proliferation, migration of TNBC cells in vitro and in vivo.
[Cell Death & Disease]
Full Article
Bookmark

No account yet? Register

0
Share

Genome Researchers Question Security Provisions in New US Senate Bill

Buried in a bill approved by the US Senate to help the United States compete with China is language that is drawing fire from human genome researchers. It would require the NIH to develop new security protocols aimed at preventing the misuse of US-funded genomic data by China and other nations.
[Science]
Editorial
Bookmark

No account yet? Register

0
Share

Vimentin Promotes the Aggressiveness of Triple Negative Breast Cancer Cells Surviving Chemotherapeutic Treatment

Persistent cells were enriched for vimentinhigh sub-population, vimentin knockdown using siRNA approach decreased the invasive and sphere forming capacities as well as Akt phosphorylation in persistent cells, indicating that vimentin was involved in chemotherapeutic treatment-induced enhancement of TNBC aggressiveness.
[Cells]
Full Article
Bookmark

No account yet? Register

0
Share

A DNA Methylation-Based Liquid Biopsy for Triple-Negative Breast Cancer

The authors presented a next-generation sequencing methylation-based blood test called methylation DETEction of Circulating Tumour DNA (mDETECT) designed for the optimal detection and monitoring of metastatic TNBC.
[npj Precision Oncology]
Full Article
Bookmark

No account yet? Register

0
Share

USP35, Regulated by Estrogen and AKT, Promotes Breast Tumorigenesis by Stabilizing and Enhancing Transcriptional Activity of Estrogen Receptor α

USP35 promoted the growth of ER+ breast cancer in vitro and in vivo, and reduced the sensitivity of ER+ breast cancer cells to endocrine therapies such as tamoxifen and fulvestrant.
[Cell Death & Disease]
Full Article
Bookmark

No account yet? Register

0
Share

Curcumin Loaded on Graphene Nanosheets Induced Cell Death in Mammospheres from MCF-7 and Primary Breast Tumor Cells

Researchers evaluated cell death in mammospheres from MCF-7 and primary tumor cells in response to curcumin loaded on graphene nanosheets. The nanocarriers graphene oxide and graphene quantum dots had no cytotoxic effect on Kerman male breast cancer/71 and MCF-7 tumor cells, while those loaded with curcumin induced death in more than 50% of tumor cells.
[Biomedical Materials]
Abstract
Bookmark

No account yet? Register

0
Share

An AIB1 Isoform Alters Enhancer Access and Enables Progression of Early Stage Triple-Negative Breast Cancer

Scientists CRISPR-engineered RNA splice junctions to produce normal and early stage ductal carcinoma in situ breast epithelial cells that expressed only AIB1Δ4. These cells showed enhanced motility and invasion in 3D cell culture.
[Cancer Research]
Abstract
Bookmark

No account yet? Register

0
Share

Integrin α2β1 Targeting DGEA-Modified Liposomal Doxorubicin Enhances Antitumor Efficacy against Breast Cancer

Investigators constructed an integrin α2β1 targeting DGEA-modified liposomal doxorubicin platform for application in breast cancer therapy. Demonstrated in vitro and in vivo, the constructed platform exhibited improved antitumor ability.
[Molecular Pharmaceutics]
AbstractGraphical Abstract
Bookmark

No account yet? Register

0
Share

Circular RNA hsa_circ_0044234 as Distinct Molecular Signature of Triple Negative Breast Cancer: A Potential Regulator of GATA3

Reverse transcription-quantitative polymerase chain reaction was performed to confirm the downregulation of circ_0044234 in triple negative tumors and cell lines versus non-triple negative ones.
[Cancer Cell International]
Full Article
Bookmark

No account yet? Register

0
Share

PI3K Inhibitors Are Finally Coming of Age

The authors summarize key discoveries that aid the clinical translation of PI3Kα and PI3Kδ inhibitors, including the PI3Kα isoform-selective inhibitor alpelisib for the treatment of breast cancer, highlighting lessons learnt and future opportunities.
[Nature Reviews Drug Discovery]
Abstract
Bookmark

No account yet? Register

0
Share
Share